Tangrenshen Group Co., Ltd (002567.SZ)
Zhuzhou, CN
Tangrenshen Group Co., Ltd is a Chinese enterprise primarily focused on the cultivation, processing, and sale of pork and animal feed. Its operations also extend to providing animal health supplies and live swine. The firm distributes its diverse product portfolio through its established brands, Tangrenshen and Camel. This company was established in 1988 and its principal office is situated in Zhuzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.83% | -1.90% | +1.73% | -4.85% | -14.88% | -6.36% | -15.23% | -42.70% | -43.02% | -69.48% | -56.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Food Distribution: +7.7%-0.5% Q1'26: -10.0% (vs Q1'25)
-
EPS growth Food Distribution: +4.1%-432.0% Q1'26: -717.8% (vs Q1'25)
-
FCF margin FCF growth · Food Distribution: +15.4%-1.0% Q1'26: -0.2% (vs Q1'25)
-
EBIT margin Food Distribution: +3.6%-3.9% Q1'26: -10.9% (vs Q1'25)
-
ROIC Food Distribution: +6.5%-11.8% Q1'26: -32.4% (vs Q1'25)
-
Share dilution Food Distribution: +0.0%-0.3% ★ Q1'26: -0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Food Distribution: 0.80×112.25× Q1'26: -2.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.41B
est: 10.83B (-13.1%)
|
10.88B
est: 10.76B (+1.2%)
|
13.74B
est: 14.30B (-3.9%)
|
15.42B
est: 15.41B (+0.1%)
|
15.36B
est: 17.09B (-10.2%)
|
18.53B
est: 18.27B (+1.4%)
|
19.35B
est.
|
21.74B
est: 24.89B (-12.6%)
|
26.54B
est: 28.06B (-5.4%)
|
26.95B
est: 28.06B (-4.0%)
|
24.34B
est: 30.75B (-20.8%)
|
24.21B
est: 25.19B (-3.9%)
|
25.03B
25.03B – 25.03B
-0.6% YoY
|
27.37B
27.37B – 27.37B
+9.3% YoY
|
27.93B
27.93B – 27.93B
+2.0% YoY
|
| EBITDA |
404.34M
est: 351.15M (+15.1%)
|
479.47M
est: 348.88M (+37.4%)
|
680.78M
est: 463.73M (+46.8%)
|
527.94M
est: 499.87M (+5.6%)
|
666.11M
est: 554.22M (+20.2%)
|
1.53B
est: 592.59M (+158.4%)
|
627.35M
est.
|
-448.04M
est: 807.01M (-155.5%)
|
1.17B
est: 910.03M (+29.1%)
|
-440.28M
est: 910.03M (-148.4%)
|
1.47B
est: 968.06M (+51.4%)
|
38.37M
est: 793.07M (-95.2%)
|
788.13M
788.13M – 788.13M
-0.6% YoY
|
861.68M
861.68M – 861.68M
+9.3% YoY
|
879.34M
879.34M – 879.34M
+2.0% YoY
|
| EBIT |
263.28M
est: 27.53M (+856.4%)
|
323.26M
est: 27.35M (+1,081.9%)
|
491.55M
est: 36.35M (+1,252.1%)
|
306.98M
est: 39.19M (+683.3%)
|
376.89M
est: 43.45M (+767.4%)
|
1.20B
est: 46.46M (+2,490.6%)
|
49.18M
est.
|
-947.63M
est: 63.27M (-1,597.8%)
|
477.93M
est: 71.34M (+569.9%)
|
-1.29B
est: 71.34M (-1,902.5%)
|
598.90M
est: -925.71M (+164.7%)
|
-933.99M
est: -758.38M (-23.2%)
|
-753.66M
-753.66M – -753.66M
+0.6% YoY
|
-823.98M
-823.98M – -823.98M
-9.3% YoY
|
-840.87M
-840.87M – -840.87M
-2.0% YoY
|
| Net Income |
81.80M
est: 171.98M (-52.4%)
|
201.02M
est: 378.35M (-46.9%)
|
310.31M
est: 601.91M (-48.4%)
|
136.93M
est: 229.30M (-40.3%)
|
202.36M
est: 759.56M (-73.4%)
|
950.34M
est: 1.61B (-40.8%)
|
-587.58M
est.
|
-1.15B
est: 200.64M (-671.9%)
|
135.19M
est: -1.36B (+109.9%)
|
-1.53B
est: -1.36B (-12.1%)
|
355.42M
est: 371.40M (-4.3%)
|
-1.19B
est: 357.11M (-432.4%)
|
-514.24M
-514.24M – -514.24M
-244.0% YoY
|
514.24M
514.24M – 514.24M
+200.0% YoY
|
685.65M
685.65M – 685.65M
+33.3% YoY
|
| SGA |
619.76M
est: 258.23M (+140.0%)
|
693.29M
est: 256.56M (+170.2%)
|
841.38M
est: 341.02M (+146.7%)
|
789.70M
est: 367.60M (+114.8%)
|
861.18M
est: 407.57M (+111.3%)
|
960.51M
est: 435.78M (+120.4%)
|
461.35M
est.
|
1.28B
est: 593.47M (+115.9%)
|
1.24B
est: 669.22M (+86.0%)
|
1.33B
est: 669.22M (+99.4%)
|
1.30B
est: 1.37B (-5.1%)
|
353.83M
est: 1.13B (-68.6%)
|
1.12B
1.12B – 1.12B
-0.6% YoY
|
1.22B
1.22B – 1.22B
+9.3% YoY
|
1.25B
1.25B – 1.25B
+2.0% YoY
|
| EPS |
0.13
est: 0.12 (+8.3%)
|
0.27
est: 0.26 (+2.3%)
|
0.39
est: 0.42 (-7.1%)
|
0.16
est: 0.16 (+0.0%)
|
0.24
est: 0.53 (-54.7%)
|
1.07
est: 1.12 (-4.5%)
|
-0.41
est.
|
-1.00
est: 0.14 (-814.3%)
|
0.11
est: -0.95 (+111.6%)
|
-1.09
est: -0.95 (-14.7%)
|
0.25
est: 0.26 (-3.8%)
|
-0.83
est: 0.25 (-432.0%)
|
-0.36
-0.36 – -0.36
-244.0% YoY
|
0.36
0.36 – 0.36
+200.0% YoY
|
0.48
0.48 – 0.48
+33.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 251.1K | 0.39% |
| 2 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 334.3K | 0.07% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 184.3K | 0.06% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 58.0K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 49.8K | 0.28% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 12.3K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 5.5K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 607.5K | 0.06% |
| 9 | Vanguard Total World Stock ETF VT | 0.00% | 158.9K | 0.06% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 9.9K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hongqing Yu | Chief Executive Officer & Director | — | male |
| Min Deng | Supervisor & Director of Customer Engineering Department | — | female |
| Shuang Sheng Sun | Secretary of the Board of Directors & Non Independent Director | — | male |
| Wei Hong Yang | Supervisor, Head of Biotechnology Branch & GM of Branches and Subsidiaries | — | male |
| Wen Zhang | Chairman of Supervisory Board & Chief Political Commissar | — | male |
| Xiangjian Deng | Supervisor & Safety Commissioner | — | male |
| Yan Xu | Deputy General Manager of Securities Department | — | — |
| Ye Tao | President & Vice Chairman | — | male |
| Zhi Yang | Chief Financial Officer, Financial Director, Accounting Supervisor & Non-Independent Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002567.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
